Literature DB >> 2282453

Phentolamine and yohimbine inhibit ATP-sensitive K+ channels in mouse pancreatic beta-cells.

T D Plant1, J C Henquin.   

Abstract

1. The effects of phentolamine and yohimbine on adenosine 5'-triphosphate (ATP)-sensitive K+ channels were studied in normal mouse beta-cells. 2. In the presence of 3 mM glucose, many ATP-sensitive K+ channels are open in the beta-cell membrane. Under these conditions, phentolamine inhibited 86Rb efflux from the islets. This inhibition was faster with 100 than with 20 microM phentolamine but its steady-state magnitude was similar with both concentrations. Yohimbine (20-100 microM) also inhibited the efflux rate but was not as potent as phentolamine. 3. In the presence of 6 mM glucose, most ATP-sensitive K+ channels are closed in the beta-cell membrane. Their opening by 100 microM diazoxide caused a marked acceleration of 86Rb efflux from the islets. This acceleration was almost entirely prevented by 20 microM phentolamine. It was barely affected by 20 microM yohimbine and reduced by 50% by 100 microM yohimbine. 4. ATP-sensitive K+ currents were studied in single beta-cells by the whole cell patch-clamp technique. Phentolamine (20-100 microM) caused a progressive but almost complete and irreversible inhibition of the current. The effects of yohimbine were faster but smaller; the inhibition was still incomplete with 100 microM yohimbine. 5. The increase in ATP-sensitive K+ current produced by 100 microM diazoxide was prevented by 100 microM phentolamine but only partially attenuated by 100 microM yohimbine. 6. It is concluded that phentolamine inhibits ATP-sensitive K+ channels in pancreatic beta-cells. This novel effect of phentolamine resembles that of hypoglycaemic sulphonylureas. It may account for previously unexplained effects of the drug. These observations also call for reinterpretation of many studies in which phentolamine was used as an allegedly specific blocker of alpha-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2282453      PMCID: PMC1917617          DOI: 10.1111/j.1476-5381.1990.tb12099.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  D-glucose inhibits potassium efflux from pancreatic islet cells.

Authors:  J C Henquin
Journal:  Nature       Date:  1978-01-19       Impact factor: 49.962

2.  Effect of alpha-adrenergic blockade on insulin secretion in man.

Authors:  M G Buse; A H Johnson; D Kuperminc; J Buse
Journal:  Metabolism       Date:  1970-03       Impact factor: 8.694

3.  Adrenergic regulation of insulin secretion during fasting in normal subjects.

Authors:  R I Misbin; P J Edgar; D H Lockwood
Journal:  Diabetes       Date:  1970-10       Impact factor: 9.461

4.  Interaction of amines and aminergic blocking agents with blood glucose regulation. II. Alpha-adrenergic blockade.

Authors:  I Lundquist
Journal:  Eur J Pharmacol       Date:  1972-05       Impact factor: 4.432

5.  Adrenergic modulation of basal insulin secretion in man.

Authors:  R P Robertson; D Porte
Journal:  Diabetes       Date:  1973-01       Impact factor: 9.461

6.  Effect of phentolamine and preperfusion with glucose on insulin release from the isolated perfused pancreas from fasted and fed rats.

Authors:  S Efendić; E Cerasi; R Luft
Journal:  Diabetologia       Date:  1975-10       Impact factor: 10.122

7.  Mechanisms of action of diazoxide.

Authors:  W G Blackard; C N Aprill
Journal:  J Lab Clin Med       Date:  1967-06

8.  A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus.

Authors:  R P Robertson; J B Halter; D Porte
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

9.  Diazoxide effects on biphasic insulin release: "adrenergic" suppression and enhancement in the perifused rat pancreas.

Authors:  I M Burr; E B Marliss; W Stauffacher; A E Renold
Journal:  J Clin Invest       Date:  1971-07       Impact factor: 14.808

10.  Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells.

Authors:  G Trube; P Rorsman; T Ohno-Shosaku
Journal:  Pflugers Arch       Date:  1986-11       Impact factor: 3.657

View more
  25 in total

Review 1.  Biological significance of agmatine, an endogenous ligand at imidazoline binding sites.

Authors:  W Raasch; U Schäfer; J Chun; P Dominiak
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells.

Authors:  J C Jonas; T D Plant; J C Henquin
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

3.  Phentolamine block of KATP channels is mediated by Kir6.2.

Authors:  P Proks; F M Ashcroft
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

4.  Multiple effector pathways regulate the insulin secretory response to the imidazoline RX871024 in isolated rat pancreatic islets.

Authors:  M Mourtada; S L Chan; S A Smith; N G Morgan
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

5.  Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release.

Authors:  R M Shepherd; M N Hashmi; C Kane; P E Squires; M J Dunne
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

6.  Attenuation by phentolamine of hypoxia and levcromakalim-induced abbreviation of the cardiac action potential.

Authors:  D Tweedie; G Boachie-Anash; C G Henderson; K A Kane
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

7.  Effects of P1060 and aprikalim on whole-cell currents in rat portal vein; inhibition by glibenclamide and phentolamine.

Authors:  T Ibbotson; G Edwards; T Noack; A H Weston
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

8.  Antagonism of levcromakalim by imidazoline- and guanidine-derivatives in rat portal vein: involvement of the delayed rectifier.

Authors:  T Ibbotson; G Edwards; A H Weston
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

9.  Improvement of Arbuscular Mycorrhiza Development by Inoculation of Soil with Phosphate-Solubilizing Rhizobacteria To Improve Rock Phosphate Bioavailability ((sup32)P) and Nutrient Cycling.

Authors:  M Toro; R Azcon; J Barea
Journal:  Appl Environ Microbiol       Date:  1997-11       Impact factor: 4.792

10.  Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites.

Authors:  C A Brown; A C Loweth; S A Smith; N G Morgan
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.